TNFi Combination Therapy, Switching and Persistence Patterns By Longitudinal Disease Activity Strata in Patients with Rheumatoid Arthritis

被引：0
|
作者：
Harrold, Leslie [1 ,2 ]
Reed, George W. [1 ,2 ]
Boytsov, Natalie [3 ]
Gaich, Carol L. [3 ]
Mason, Marc [2 ]
Zhang, Xiang [3 ]
Larmore, Cynthia J. [3 ]
Deveikis, Sabrina [2 ]
Araujo, Andre B. [3 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Corrona LLC, Southborough, MA USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1637
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia
    Paul Bird
    Geoffrey Littlejohn
    Belinda Butcher
    Tegan Smith
    Catherine O’Sullivan
    David Witcombe
    Hedley Griffiths
    Clinical Rheumatology, 2022, 41 : 53 - 62
  • [32] Real-world Persistence of Initial Targeted Therapy Strategy in Monotherapy versus Combination Therapy in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Sanchez-Piedra, Carlos
    Exposito, Lorena
    Vela, Paloma
    Moreno Ramos, Manuel Jose
    Campos, Cristina
    Bohorquez, Cristina
    Calvo, Jerusalem
    Plaza, Zulema
    Dominguez, Marta
    Diaz-Gonzalez, Jose Federico
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4272 - 4275
  • [33] No change in treatment despite persistence of clinical activity in patients with rheumatoid arthritis
    Harrison, MJ
    Gibofsky, A
    Keystone, E
    Xia, HA
    Louie, J
    White, B
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S720 - S720
  • [34] Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis
    Blank, Norbert
    Max, Regina
    Schiller, Martin
    Briem, Steffen
    Lorenz, Hanns-Martin
    RHEUMATOLOGY, 2009, 48 (04) : 440 - 441
  • [35] Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis
    Mroczkowski, PJ
    Weinblatt, ME
    Kremer, JM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S66 - S68
  • [36] COMBINATION METHOTREXATE AND SULFASALAZINE THERAPY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    MORAND, EF
    AXTENS, RSK
    LITTLEJOHN, GO
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S53 - S53
  • [37] Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis
    Çalgüneri, M
    Pay, S
    Çaliskaner, Z
    Apras, S
    Kiraz, S
    Ertenli, I
    Çobankara, V
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : 699 - 704
  • [38] Persistence and Predictors of Biologic TNFi Therapy Among Biologic naive Psoriatic Arthritis Patients in a US Registry.
    Mease, Philip
    Collier, David
    Karki, Chitra
    Li, Guo
    Bitman, Bojena
    Greenberg, Jeffrey D.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S815 - S815
  • [39] Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic
    Johnston S.S.
    McMorrow D.
    Farr A.M.
    Juneau P.
    Ogale S.
    Rheumatology and Therapy, 2015, 2 (1) : 59 - 71
  • [40] The persistence of abnormal T-cell differentiation patterns predicts relapse in rheumatoid arthritis patients with controlled disease
    A Brown
    F Ponchel
    J Isaacs
    P Emery
    Arthritis Research & Therapy, 7
12345